| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.39 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |